Halifax-based MedMira has announced it has finished developing a serological Point-of-Care (POC) testing solution for COVID-19
The test, REVEALCOVID19, delivers immediate results without the need for additional equipment. It can be used with whole blood, serum or plasma and is ideal for batch testing in laboratory settings, thus meeting the needs of users across a broad range of testing environments, the company said in a statement.
MedMira is a developer and manufacturer of vertical flow rapid diagnostics (tests that combine liquids with reactive molecules to give a result). The company’s
